Wangjie Jiang

800 total citations
30 papers, 555 citations indexed

About

Wangjie Jiang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wangjie Jiang has authored 30 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Surgery and 13 papers in Cancer Research. Recurrent topics in Wangjie Jiang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (9 papers). Wangjie Jiang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (9 papers). Wangjie Jiang collaborates with scholars based in China, United Kingdom and Taiwan. Wangjie Jiang's co-authors include Xiangcheng Li, Yaodong Zhang, Yu‐Dong Zhang, Xuehao Wang, Yongxiang Xia, Gu‐Wei Ji, Feipeng Zhu, Ke Wang, Hui Zhang and Changxian Li and has published in prestigious journals such as Nature Communications, Oncogene and Radiology.

In The Last Decade

Wangjie Jiang

29 papers receiving 553 citations

Peers

Wangjie Jiang

RNMI

SURGE

PRM

ONCOL

Alessandra Alessi Italy

Chao‐Nan Qian China

Matilde Cacciatore Italy

Zepang Sun China

Xiuxin Han China

Zhe Jin China

Xiaochu Yan China

Stephen Raskin Israel

Wendong Gu China

Alessandra Alessi Italy

Wangjie Jiang

219 ×1.0

RNMI

153 ×0.7

SURGE

122 ×0.7

PRM

206 ×1.2

ONCOL

93 ×0.6

Citations per year, relative to Wangjie Jiang Wangjie Jiang (= 1×) peers Alessandra Alessi

Countries citing papers authored by Wangjie Jiang

Since Specialization

Citations

This map shows the geographic impact of Wangjie Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjie Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjie Jiang more than expected).

Fields of papers citing papers by Wangjie Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangjie Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjie Jiang. The network helps show where Wangjie Jiang may publish in the future.

Co-authorship network of co-authors of Wangjie Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wangjie Jiang. A scholar is included among the top collaborators of Wangjie Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangjie Jiang. Wangjie Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jifei, Qinfeng Xu, Hongwei Wang, et al.. (2025). Aldose reductase -mediated HUR ubiquitination enhances exosome release and hepatic fibrosis via ROS/PI3K/AKT pathway. Free Radical Biology and Medicine. 236. 1–16.

Zhou, Tao, Yaodong Zhang, Jiang Chang, et al.. (2025). NRXN3 regulates pyroptosis in intrahepatic cholangiocarcinoma via mediating the phospho-dependent ubiquitination and degradation of caspase-3. Journal of Advanced Research. 80. 655–669. 1 indexed citations

Qiao, Qian, Jifei Wang, Jiang Chang, et al.. (2024). USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma. Cellular Oncology. 47(6). 2217–2231. 3 indexed citations

Chang, Jiang, Yaodong Zhang, Tao Zhou, et al.. (2024). RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 104–104. 6 indexed citations

Wang, Yirui, Ming Ni, Ruixiang Chen, et al.. (2024). Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway. Free Radical Biology and Medicine. 220. 78–91. 2 indexed citations

Wang, Yuming, Yiwei Liu, Hairong Chen, et al.. (2024). PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2. Cellular Oncology. 47(4). 1233–1252. 4 indexed citations

Yang, Xiao, Mingyu Wu, Yun Wang, et al.. (2024). Exosomal miR-3174 induced by hypoxia promotes angiogenesis and metastasis of hepatocellular carcinoma by inhibiting HIPK3. iScience. 27(2). 108955–108955. 12 indexed citations

Wang, Yirui, Shilong Fan, Chang Li, et al.. (2024). CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma. Molecular Cancer. 23(1). 35–35. 14 indexed citations

Shi, Xiaoli, Wei‐Wen Chen, Xinyi Wang, et al.. (2024). RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis. Cancer Letters. 592. 216909–216909. 8 indexed citations

10.

Fan, Shilong, Yirui Wang, Ruixiang Chen, et al.. (2023). ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma. BMC Cancer. 23(1). 444–444. 10 indexed citations

11.

Li, Siheng, Yichun Yin, Cheng Yang, et al.. (2023). NewsDialogues: Towards Proactive News Grounded Conversation. arXiv (Cornell University). 3634–3649. 2 indexed citations

12.

Jiang, Wangjie, Zhihao Ye, Bang Liu, et al.. (2023). ICA-Proto: Iterative Cross Alignment Prototypical Network for Incremental Few-Shot Relation Classification. 2275–2284. 2 indexed citations

13.

Li, Siheng, Wangjie Jiang, Cheng Yang, et al.. (2023). Enhancing Dialogue Generation with Conversational Concept Flows. 3 indexed citations

14.

Jiang, Wangjie, Tao Zhou, Yaodong Zhang, et al.. (2023). NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1. International Journal of Biological Sciences. 19(5). 1336–1351. 13 indexed citations

15.

Jiang, Wangjie, Xiao Yang, Yaodong Zhang, et al.. (2023). MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex. Oncogene. 42(45). 3344–3357. 10 indexed citations

16.

Wang, Yirui, Yaodong Zhang, Tao Zhou, et al.. (2023). Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. Journal of Experimental & Clinical Cancer Research. 42(1). 265–265. 26 indexed citations

17.

Jiang, Wangjie, Xiaoli Shi, Yaodong Zhang, et al.. (2023). Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner. International Journal of Biological Sciences. 19(14). 4571–4587. 12 indexed citations

18.

Ma, Zijian, Changxian Li, Wangjie Jiang, et al.. (2022). The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nature Communications. 13(1). 38 indexed citations

19.

Zhou, Tao, Yaodong Zhang, Jifei Wang, et al.. (2022). ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal. Frontiers in Oncology. 12. 879963–879963. 2 indexed citations

20.

Ji, Gu‐Wei, Yu‐Dong Zhang, Hui Zhang, et al.. (2018). Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 290(1). 90–98. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact